A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Union, joined at a press conference Monday by Brad Schnure, a 48-year-old former senior state employee who is battling stage IV lung cancer, said he has a solution to frustrating denials: Pass ...

With tumor reduction seen in 48% of the 33 patients studied, the combination treatment had an overall response rate of 21% in ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Mayo Clinic announces the results of an innovative treatment approach that may offer improvement in overall survival in older ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall ...

Bobbi Conner talks with MUSC's Dr. Tucker Marrison about cancer screening recommendations for adults, with an update about ...

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.